<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Alosco ML</submitter><funding>American Heart Association</funding><funding>BU-CTSI</funding><funding>NCATS NIH HHS</funding><funding>NIA NIH HHS</funding><funding>Alzheimer's Drug Discovery Foundation</funding><funding>National Institute of Neurological Disorders and Stroke &amp; National Institute on Aging</funding><funding>NINDS NIH HHS</funding><funding>Gates Ventures</funding><funding>Alzheimer's Research UK</funding><pagination>e70654</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12418077</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(9)</volume><pubmed_abstract>We describe the rationale, methodology, and design of the Boston University Alzheimer's Disease Research Center (BU ADRC) Clinical Core (CC). The CC characterizes a longitudinal cohort of participants with/without brain trauma to characterize the clinical presentation, biomarker profiles, and risk factors of post-traumatic Alzheimer's disease (AD) and AD-related dementias (ADRD), including chronic traumatic encephalopathy (CTE). Participants complete assessments of traumatic brain injury (TBI) and repetitive head impacts (RHIs); annual Uniform Data Set (UDS) and supplementary evaluations; digital phenotyping; annual blood draw; magnetic resonance imaging (MRI) and lumbar puncture every 3 years; electroencephalogram (EEG); and amyloid and/or tau positron emission tomography (PET) on a subse</pubmed_abstract><journal>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</journal><pubmed_title>Boston University Alzheimer's Disease Research Center Clinical Core: Infrastructure to facilitate research on post-traumatic Alzheimer's disease and related dementias.</pubmed_title><pmcid>PMC12418077</pmcid><funding_grant_id>R01 AG083735</funding_grant_id><funding_grant_id>R01 NS122854</funding_grant_id><funding_grant_id>UL1 TR001430</funding_grant_id><funding_grant_id>R01NS122854</funding_grant_id><funding_grant_id>20SFRN35360180</funding_grant_id><funding_grant_id>RDADB-202104-2021750</funding_grant_id><funding_grant_id>R01AG083735</funding_grant_id><funding_grant_id>ARUK-EDoN24-004</funding_grant_id><funding_grant_id>1UL1TR001430</funding_grant_id><funding_grant_id>P30 AG072978</funding_grant_id><funding_grant_id>P30AG072978</funding_grant_id><pubmed_authors>Mez J</pubmed_authors><pubmed_authors>Jun G</pubmed_authors><pubmed_authors>Goldstein LE</pubmed_authors><pubmed_authors>Mwicigi J</pubmed_authors><pubmed_authors>Budson AE</pubmed_authors><pubmed_authors>Palmisano J</pubmed_authors><pubmed_authors>Schneider G</pubmed_authors><pubmed_authors>McKee AC</pubmed_authors><pubmed_authors>Alosco ML</pubmed_authors><pubmed_authors>Dixon D</pubmed_authors><pubmed_authors>Turk KW</pubmed_authors><pubmed_authors>Au R</pubmed_authors><pubmed_authors>Nowinski C</pubmed_authors><pubmed_authors>Altaras C</pubmed_authors><pubmed_authors>Ellison A</pubmed_authors><pubmed_authors>Qiu WQ</pubmed_authors><pubmed_authors>Groh JR</pubmed_authors><pubmed_authors>Martin B</pubmed_authors><pubmed_authors>Stein TD</pubmed_authors><pubmed_authors>Abdennadher M</pubmed_authors><pubmed_authors>Steinberg EG</pubmed_authors><pubmed_authors>O'Connor MK</pubmed_authors><pubmed_authors>Cantu RC</pubmed_authors><pubmed_authors>Tripodis Y</pubmed_authors><pubmed_authors>Farrer L</pubmed_authors><pubmed_authors>Lenio S</pubmed_authors><pubmed_authors>Farris CW</pubmed_authors><pubmed_authors>Morrison M</pubmed_authors><pubmed_authors>Ly M</pubmed_authors><pubmed_authors>Sheppard D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Boston University Alzheimer's Disease Research Center Clinical Core: Infrastructure to facilitate research on post-traumatic Alzheimer's disease and related dementias.</name><description>We describe the rationale, methodology, and design of the Boston University Alzheimer's Disease Research Center (BU ADRC) Clinical Core (CC). The CC characterizes a longitudinal cohort of participants with/without brain trauma to characterize the clinical presentation, biomarker profiles, and risk factors of post-traumatic Alzheimer's disease (AD) and AD-related dementias (ADRD), including chronic traumatic encephalopathy (CTE). Participants complete assessments of traumatic brain injury (TBI) and repetitive head impacts (RHIs); annual Uniform Data Set (UDS) and supplementary evaluations; digital phenotyping; annual blood draw; magnetic resonance imaging (MRI) and lumbar puncture every 3 years; electroencephalogram (EEG); and amyloid and/or tau positron emission tomography (PET) on a subse</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-02T17:40:51.295Z</modification><creation>2026-04-18T03:11:28.828Z</creation></dates><accession>S-EPMC12418077</accession><cross_references><pubmed>40923312</pubmed><doi>10.1002/alz.70654</doi></cross_references></HashMap>